The civic record
Read. Follow. Verify.Missouri Senate Bill 1069 raises annual purchase limits on cold and allergy medications containing pseudoephedrine and imposes new tracking system fees on drug manufacturers
Last action · April 8, 2026: SCS Voted Do Pass S Families, Seniors and Health Committee (4496S.02C)Sponsor: Mike Henderson
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Would Do
This bill increases the allowable twelve-month purchase limit for over-the-counter cold and allergy medications containing , ephedrine, or phenylpropanolamine from 43.2 grams to 61.2 grams. Beginning October 1, 2026, it requires manufacturers of these precursors to pay monthly fees to the tracking system administrator and establishes criminal penalties for non-payment. Additionally, the measure preempts local municipal regulations and mandates that these products remain stored behind pharmacy counters.
Residents seeking cold or allergy relief face a higher annual purchase threshold, while drug manufacturers face new recurring fees for distributing precursor products within the state.
- Pseudoephedrine and related compounds are tightly regulated precursors because they can be chemically processed to produce methamphetamine. context
- Missouri utilizes a real-time electronic tracking system to monitor sales of over-the-counter cold and allergy medications containing pseudoephedrine across retail pharmacies. context
Who It Would Affect
Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.
Consumers
Consumers face a new twelve-month purchase limit of 61.2 grams for over-the-counter precursor medications and must continue purchasing products from behind pharmacy counters.
Manufacturers
Manufacturers of pseudoephedrine products must pay monthly fees to the electronic tracking system administrator starting October 1, 2026, and face class A misdemeanor penalties for non-payment.
Pharmacists and Pharmacy Technicians
Pharmacists and pharmacy technicians must continue enforcing retail limits, maintaining electronic logs, and managing behind-the-counter sales restrictions.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
What is the new annual purchase limit for cold and allergy medications containing pseudoephedrine?
Who is required to pay the new monthly tracking system fees?
Where must pseudoephedrine products be displayed in stores?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
Currently in committee. The next step in the legislative lifecycle is Floor Vote.
Procedural history
5 actions- Apr 8, 2026SenateCommitteeSCS Voted Do Pass S Families, Seniors and Health Committee (4496S.02C)
- Feb 11, 2026SenateHearing Conducted S Families, Seniors and Health Committee
- Jan 15, 2026SenateFloorSecond Read and Referred S Families, Seniors and Health Committee
- Jan 7, 2026SenateIntroducedS First Read
- Dec 1, 2025SenatePrefiled
Version history & redline
2 versions on fileLobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Expansion of Precursor Purchase Thresholds
The legislation raises the annual cap on over-the-counter cold and allergy medications containing pseudoephedrine by 18 grams.
Connected Entities
Sources
www.senate.mo.gov
Analysis Score
0–100- Significance60How much this matters to a regular citizen
- Controversy25Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz20Current news / social attention level
Publisher tools
